| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | bivalirudin | FAERS: 30 | US FAERS | |
| 2 | ioversol | FAERS: 3 | OFFSIDES US FAERS | |
| 3 | Celecoxib | FAERS: 2 | US FAERS | |
| 4 | Dabigatran | FAERS: 2 | US FAERS | |
| 5 | Omeprazole | FAERS: 2 | US FAERS | |
| 6 | Paclitaxel | FAERS: 2 | US FAERS | |
| 7 | rofecoxib | FAERS: 2 | OFFSIDES US FAERS | |
| 8 | Adzenys XR-ODT | FAERS: 1 | US FAERS | |
| 9 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 10 | Prasugrel Hydrochloride | FAERS: 1 | US FAERS | |
| 11 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 12 | Tamoxifen | FAERS: 1 | US FAERS | |
| 13 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 14 | Atropine | OFFSIDES | ||
| 15 | Epinephrine | OFFSIDES | ||
| 16 | Eptifibatide | OFFSIDES | ||
| 17 | Lidoderm | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.